Cargando…
COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID-19). The virus invades human cells through the angiotensin-converting enzyme 2 (ACE2) receptor-driven pathway, primarily targeting th...
Autores principales: | Achar, Aneesha, Ghosh, Chaitali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692725/ https://www.ncbi.nlm.nih.gov/pubmed/33120941 http://dx.doi.org/10.3390/cells9112360 |
Ejemplares similares
-
Drug Delivery Challenges in Brain Disorders across the Blood–Brain Barrier: Novel Methods and Future Considerations for Improved Therapy
por: Achar, Aneesha, et al.
Publicado: (2021) -
Multiple hurdle mechanism and blood-brain barrier in epilepsy: glucocorticoid receptor-heat shock proteins on drug regulation
por: Achar, Aneesha, et al.
Publicado: (2021) -
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2
por: Krasemann, Susanne, et al.
Publicado: (2022) -
Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview
por: Archie, Sabrina Rahman, et al.
Publicado: (2021) -
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
por: Kanwar, Jagat R, et al.
Publicado: (2012)